EP-1242 OPTIMIZATION OF DOSE PRESCRIPTION IN SKIN CARCINOMAS RADIOTHERAPY: HOW TO USE BOLUSES EFFECTIVELY? von Camilleri, J, Laprie, A, Kerjean, P, Kerjean, J.C, Gros-Dagnac, H, Moyal, E, Delannes, M, Ken, S, Franceries, X

Volltext

205 ALTERNATIVE UTILIZATION OF BOLUS IN SKIN CARCINOMAS CANCERS TREATED WITH HIGH ENERGY ELECTRON BEAMS IN ORDER TO OPTIMIZE THE DOSE PRESCRIPTION von Camilleri, J, Ken, S, Laprie, A, Sors, A, Chauveau, N, Kerjean, P, Kerjean, J.C, Gros-Dagnac, H, Moyal, E. Cohen-Jonathan, Delannes, M, Franceries, X

Volltext

54 Loss of maternal-specific methylation at the l'insuline growth factor 2 (IGF2) locus is a predictive factor for the occurrence of hepatocellular carcinoma (HCC) in hepatitis C v... von Ganne-Carrié, N., Paries, J., Carrié, A., Couvert, P., Kerjean, A., Trinchet, J.C., Beaugrand, M.

Volltext

Lipomatose cardiaque symptomatique : Une complication exceptionnelle de la corticothérapie von Cador-Rousseaul, B., Kerjean, M., Meunier, C., Daubert, J.C., Grosbois, B.

Volltext